The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Isotretinoin 5 mg soft capsules

5 milligram(s) Capsule, soft

Rowex LtdPA0711/312/001

Main Information

Trade NameIsotretinoin 5 mg soft capsules
Active SubstancesIsotretinoin
Strength5 milligram(s)
Dosage FormCapsule, soft
Licence HolderRowex Ltd
Licence NumberPA0711/312/001

Group Information

ATC CodeD10BA01 isotretinoin


Licence Issued12/06/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Educational Materials - HCP

Educational Materials - Patient

« Back